UMOD and autosomal dominant polycystic kidney disease: For example, if the effect of ALG5 variant on uromodulin synthesis leads to CKD, the downregulation of uromodulin production could be a potential therapy for patients with ADPKD-ALG5 (as well as ADPKD-ALG8).